Hepatitis C Treatments
Find Hepatitis C Treatments
Medications for Hepatitis C
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hepatitis C.
Found 4 Approved Drugs for Hepatitis C
Sofosbuvir
Brand Names
Epclusa, Harvoni, Ledipasvir, Sovaldi, Vosevi
Sofosbuvir
Brand Names
Epclusa, Harvoni, Ledipasvir, Sovaldi, Vosevi
Form: Pellet, Tablet
Method of administration: Oral
FDA approval date: December 06, 2013
Classification: Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
EPCLUSA is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection [see Dosage and Administration.
Lamivudine
Brand Names
Abacavir, Cimduo, Combivir, Delstrigo, Dovato, Efavirenz, Epivir, SYMFI, Triumeq
Lamivudine
Brand Names
Abacavir, Cimduo, Combivir, Delstrigo, Dovato, Efavirenz, Epivir, SYMFI, Triumeq
Form: Tablet, Kit, Solution
Method of administration: Oral
FDA approval date: October 04, 2010
Classification: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Abacavir and lamivudine tablet, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 ) Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
Zepatier
Generic Name
Elbasvir
Zepatier
Generic Name
Elbasvir
Form: Tablet
Method of administration: Oral
FDA approval date: January 28, 2016
Classification: Hepatitis C Virus NS3/4A Protease Inhibitor
ZEPATIER ® is indicated for the treatment of chronic hepatitis C virus (HCV) genotype 1 or 4 infection in adult and pediatric patients 12 years of age and older or weighing at least 30 kg. ZEPATIER is indicated for use with ribavirin in certain patient populations [see Dosage and Administration.
Eltrombopag
Brand Names
Alvaiz, Eltrombopag Olamine, Promacta
Eltrombopag
Brand Names
Alvaiz, Eltrombopag Olamine, Promacta
Form: Tablet, Powder
Method of administration: Oral
FDA approval date: April 01, 2016
Classification: Thrombopoietin Receptor Agonist
ALVAIZ is a thrombopoietin receptor agonist indicated: for the treatment of thrombocytopenia in adult and pediatric patients 6 years and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. ALVAIZ should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding.
Showing 1-4 of 4
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances